1. Home
  2. APYX vs AGEN Comparison

APYX vs AGEN Comparison

Compare APYX & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$4.10

Market Cap

159.0M

Sector

Health Care

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.59

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
AGEN
Founded
1982
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.0M
147.4M
IPO Year
1995
1999

Fundamental Metrics

Financial Performance
Metric
APYX
AGEN
Price
$4.10
$3.59
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$6.50
$14.50
AVG Volume (30 Days)
222.2K
889.8K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
19.40
100.00
EPS
N/A
1.02
Revenue
N/A
$42,877,086.00
Revenue This Year
$11.93
$107.63
Revenue Next Year
$11.01
N/A
P/E Ratio
N/A
$3.48
Revenue Growth
N/A
89.95
52 Week Low
$1.34
$2.71
52 Week High
$4.50
$7.34

Technical Indicators

Market Signals
Indicator
APYX
AGEN
Relative Strength Index (RSI) 58.22 45.15
Support Level $3.39 $2.91
Resistance Level $4.28 $4.25
Average True Range (ATR) 0.37 0.25
MACD 0.10 -0.06
Stochastic Oscillator 81.52 35.51

Price Performance

Historical Comparison
APYX
AGEN

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: